Article
Evaluation of the Aptima HBV Quant assay vs. the COBAS TaqMan HBV test using the high pure system for the quantitation of HBV DNA in plasma and serum samples.
Clinical chemistry and laboratory medicine - 28 Mar 2018
Schalasta Gunnar, Börner Anna, Speicher Andrea, Enders Martin
Abstract excerpt
BACKGROUND: Proper management of patients with chronic hepatitis B virus (HBV) infection requires monitoring of plasma or serum HBV DNA levels using a highly sensitive nucleic acid amplification test. Because commercially available assays differ in performance, we compared herein the performance of the Hologic Aptima HBV Quant assay (Aptima) to that of the Roche Cobas TaqMan HBV test for use with the high pure...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
